Emergence of community-associated methicillin-resistant Staphylococcus aureus associated with pediatric infection in Cambodia.
BACKGROUND
The incidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is rising in the developed world but appears to be rare in developing countries. One explanation for this difference is that resource poor countries lack the diagnostic microbiology facilities necessary to detect the presence of CA-MRSA carriage and infection.


RESULTS
We developed diagnostic microbiology capabilities at the Angkor Hospital for Children, Siem Reap, western Cambodia in January 2006 and in the same month identified a child with severe community-acquired impetigo caused by CA-MRSA. A study was undertaken to identify and describe additional cases presenting between January 2006 and December 2007. Bacterial isolates underwent molecular characterization using multilocus sequence typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for the presence of the genes encoding Panton-Valentine Leukocidin (PVL). Seventeen children were identified with CA-MRSA infection, of which 11 had skin and soft tissue infection and 6 had invasive disease. The majority of cases were unrelated in time or place. Molecular characterization identified two independent MRSA clones; fifteen isolates were sequence type (ST) 834, SCCmec type IV, PVL gene-negative, and two isolates were ST 121, SCCmec type V, PVL gene-positive.


CONCLUSIONS
This represents the first ever report of MRSA in Cambodia, spread of which would pose a significant threat to public health. The finding that cases were mostly unrelated in time or place suggests that these were sporadic infections in persons who were CA-MRSA carriers or contacts of carriers, rather than arising in the context of an outbreak.
Chheng
Kheng
K
Angkor Hospital for Children, Siem Reap, Kingdom of Cambodia.
Tarquinio
Sarah
S
Wuthiekanun
Vanaporn
V
Sin
Lina
L
Thaipadungpanit
Janjira
J
Amornchai
Premjit
P
Chanpheaktra
Ngoun
N
Tumapa
Sarinna
S
Putchhat
Hor
H
Day
Nicholas P J
NP
Peacock
Sharon J
SJ
D002160:Cambodia / Q000453:epidemiology; D002648:Child; D002876:Chromosomes, Bacterial; D017714:Community-Acquired Infections / Q000453:epidemiology* / Q000382:microbiology; D006801:Humans; D015994:Incidence; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification*; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology
J Antimicrob Chemother. 2007 Nov;60(5):1108-14
17884831
Clin Infect Dis. 1999 Nov;29(5):1128-32
10524952
N Engl J Med. 2005 Apr 7;352(14):1436-44
15814879
JAMA. 1998 Feb 25;279(8):593-8
9486753
BMC Infect Dis. 2007 Jun 01;7:51
17543109
J Med Assoc Thai. 2006 Nov;89 Suppl 5:S106-17
17722301
J Clin Microbiol. 2007 Dec;45(12):3930-4
17942648
JAMA. 2007 Oct 17;298(15):1763-71
17940231
Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):729-33
17647034
Hawaii Med J. 2002 Oct;61(10):231-2
12491764
Antimicrob Agents Chemother. 2007 Jan;51(1):264-74
17043114
Int J Antimicrob Agents. 2008 May;31(5):401-10
18342492
J Clin Microbiol. 2003 Oct;41(10):4740-4
14532213
J Clin Microbiol. 2000 Mar;38(3):1008-15
10698988
Arch Intern Med. 2008 Jul 28;168(14):1585-91
18663172
Clin Infect Dis. 2002 Oct 1;35(7):819-24
12228818
J Clin Microbiol. 2004 Feb;42(2):825-8
14766862
PLoS One. 2007 Sep 05;2(9):e822
17786194
Emerg Infect Dis. 2003 Aug;9(8):978-84
12967497
N Engl J Med. 2006 Aug 17;355(7):666-74
16914702
JAMA. 1999 Sep 22-29;282(12):1123-5
10501104
J Clin Microbiol. 2002 Nov;40(11):4289-94
12409412
Diagn Microbiol Infect Dis. 2013 Sep;77(1):20-4
18394845
Diagn Microbiol Infect Dis. 2008 Dec;62(4):437-9
18842374
J Antimicrob Chemother. 2002 Dec;50(6):825-31
12461000
Ann Intern Med. 2006 Mar 7;144(5):309-17
16520471
Lancet. 2002 Mar 2;359(9308):753-9
11888586